BERMUDA-BUSINESS-DEVELOP
24.5.2023 16:10:33 CEST | Business Wire | Press release
Suzanne Johnson, Senior Advisor, United Nations (UN) Global Compact Ocean Stewardship Coalition, is the latest addition to the impressive list of speakers at the second annual Bermuda Climate Summit, presented by the Bermuda Business Development Agency (BDA), in partnership with KBRA.
Bermuda’s Deputy Premier, The Hon. Walter Roban, JP, MP, will open the Summit on June 26 with a conversation with Jim Nadler, President & CEO, KBRA. Another luncheon keynote will be given by Joshua Rosenberg, Chief Risk Officer, Federal Reserve Bank of New York on June 27.
Suzanne Johnson said, “It will be a pleasure to discuss the UN Global Compact work to advance a more sustainable ocean economy at the Bermuda Climate Summit. I look forward to discussing how ocean industry and finance can help to address the climate and nature crisis with financial service executives, academics and international regulators in attendance at the summit.”
David Hart, CEO, BDA said, “We are honoured to have a leading expert like Suzanne Johnson giving a keynote at our Bermuda Climate Summit joining an already impressive line-up. It is sure to be an incredible two days of informative and collaborative discussions not just about climate related challenges, but how Bermuda is the perfect place to create and deliver innovative solutions to the global marketplace.”
We are strongly encouraging prospective delegates from overseas to secure their room and receive special rates at our event hotel, the Hamilton Princess & Beach Club, by booking online prior to May 25. Click here to register – this year’s theme is: ‘Bermuda - Climate Central’.
Stay tuned to the BDA website for agenda updates– sessions confirmed to date include: Impact of a Changing Climate on Atlantic Hurricane Frequency and Severity moderated by Marla Pourrabbani, Data Scientist, Senior Manager, ESG and Sustainability, Deloitte, with panellists: Dr. Pete Dailey, Head of Research, Aeolus, Liz Henderson, Co-Head Catastrophe Analytics, Executive Managing Director, Reinsurance Solutions, Aon, Dr. Peter Sousounis, Vice President/Director Climate Change Research, Verisk, and Craig Tillman, President, RenaissanceRe Risk Sciences.
How Do You Measure Environmental Impact? will be moderated by Barclay Palmer, Executive Editor and Head of Strategy, Climate and Capital Media, and include panellists, Kevin Cei, Climate and Weather Solutions Executive, Jupiter Intelligence, Michele DeMers, CEO, Boundless Impact Research & Analytics, and Keith Pitts, SVP, Sustainability and Regulatory Strategy, Bioceres Crop Solutions.
What’s Ahead in the United States? will be moderated by John Huff, President & CEO, Association of Bermuda Insurers and Reinsurers (ABIR) and include panellists, Ricardo Lara, Insurance Commissioner, California Department of Insurance, Co-Chair of the NAIC Climate and Resiliency Task Force and Lori Wing-Heier, Director, Alaska Division of Insurance, Co-Chair of the NAIC Climate and Resiliency Task Force.
ESG: Where Does the Road Go From Here? will be moderated by Victoria Harman, Founder and Principal, VL Harmon Advisors, and will include panellists, Prabh Banga, VP Sustainability, Aecon, Harry Masters, Director, Advancing Green, Caroline McGill, Principal, Sustainability, and Impact Investment Strategy, Hillbreak and Patrick Welch, Chief ESG and Ratings Policy Officer, KBRA.
Green Opportunities, an Investor’s Perspective will be moderated by Bill Cox, Global Head of Corporate, Financial and Government Ratings, KBRA, with panellists Alexandra Cooley, Chief Investment Officer, Nuveen, Andrea Griffin, Global Head of Responsible Investments Specialists, HSBC Asset Management and Steve Hatfield, US Head of ESG, Carlyle Group.
Global Climate Risk will be moderated by Jeane Nikolai, Director of Energy, Government of Bermuda, and will include panellists Dr. Mark Guishard, Chartered Meteorologist, Adjunct Scientist and Trustee, BIOS, Dr. Raveem Ismail, Head of Parametric Underwriting, Africa Specialty Risks (ASR Re) and Dr. Simon Young, Senior Director, Willis Towers Watson.
Biodiversity: Our Strongest Natural Defense Against Climate Change will be moderated by Slav Gatchev, Managing Director, Sustainable Debt, The Nature Conservancy, with panellists, Osho Jha, CEO & Co-Founder at dClimate, Co-Founder & Chief Data Scientist at Arbol Inc, James Kench, Head of Insurance, KITA, and Natalia Moudrak, Climate Resiliency Leader, AON.
Climate and the Evolving Regulatory and Reporting Landscape will be moderated by Suzanne Williams-Charles, Director of Policy and Regulation, Corporate Secretary and Data Privacy Officer, ABIR, and feature panellists Ralf Kuerzdoerfer, Deputy Director, Supervision (Insurance), Bermuda Monetary Authority, Sohini Chowdhury, Senior Director, Moody’s Analytics, Ricardo Lara, Insurance Commissioner, California Department of Insurance and Arnaud van Dijk, Partner, ESG, KPMG.
The U.S. Federal Flood Programme and the (Re)Insurance Sector, will be moderated by Peter Giacone, Global Head of Insurance, KBRA and include panelists, Chris Brown – Partner, Mindset, Chlora Lindley-Myers, NAIC President and Director of the Missouri Department of Commerce and Insurance, and Andy Neal, Managing Director, Public Private Partnerships, Aon.
Net Zero? will be moderated by Miqdaad Versi, Head of ESG, Oxbow Partners, UK, and feature panelists Rachael Dalheise. Head of Sustainability, Convex, Andrew MacFarlane, Head of Climate, AXA XL, a Division of AXA, Andrew Smith, Chief Risk and Sustainability Officer, Conduit Re and Dr. Steve Smith- Head of Research & Development, Vantage.
The Power of Partnerships, which will be moderated by Jeff Manson, SVP Underwriting and Head of Global Public Sector Partnership, Renaissance Re Ltd, and will include panellists, Ekhosuehi Iyahen, Secretary General, Insurance Development Forum, Sid Miller, Director, Climate Wise, Rebekah Clement, Head of Sustainability, Lloyds, and Chair of SMI Climate Action Committee, and Tim Nielander, Founder and President, GP3 Institute.
Deep Ocean Solutions will be moderated by William Curry, President and CEO, BIOS, and feature panelists Neil Eckert, Executive Chairman, Conduit Re, Irene Polnyi- Additional Ventures Affiliate, and Mallory Ringham, PhD Chemical Oceanography, Ebb Carbon.
The BDA is grateful for the continued support of our headline sponsor KBRA, as well as: diamond sponsor Conduit Re; platinum sponsor Aon; gold sponsors Deloitte, Fidelis and Hub Culture; and silver sponsors Aeolus, Aspen, AXA XL, Belco, and KPMG. Our supporting sponsors are Butterfield and HSBC. Our media partners are The Insurer, Insurance Insider and Bermuda:Re+ILS. Our spirits partner is Goslings. Other sponsorship opportunities are still available; please e-mail bermudaclimate@bda.bm if you wish to participate.
CONNECTING BUSINESS
The BDA encourages direct investment and helps companies start up, re-locate, or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230524005581/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Galderma Provides Progress Update Regarding RelabotulinumtoxinA Regulatory Submission in the United States1.7.2026 07:00:00 CEST | Press release
Galderma received a Complete Response Letter from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization Relfydess is approved in 33 markets and already launched in more than 20, including across Europe, the Middle East and Australia, with an encouraging early launch trajectory supported by positive healthcare professional feedback Regulatory filings in other territories are ongoing and remain on track Ad hoc announcement pursuant to Art. 53 LR Galderma (SIX: GALD) today provided progress updates regarding the regulatory review of its pending Biologics License Application (“BLA”) for RelabotulinumtoxinA with the U.S. Food and Drug Administration (“FDA”). The Company has received a Complete Response Letter (CRL) from the FDA with comments related to observations during manufacturing site inspection and analytical method optimization. As part of its review, the FDA conducted a Pre-License Inspection (PLI) of Galderma’s manufa
EVE Energy Showcases All-Scenario Energy Storage Solutions at The Smarter E Europe 20261.7.2026 03:45:00 CEST | Press release
EVE Energy unveiled its Mr. Big Family series, a 6.9+ MWh energy storage system, and all-scenario energy storage solutions at Intersolar Europe in Munich. Drawing on traceable large-cell technology, proven large-scale energy storage project delivery experience, and global delivery capabilities, the company is addressing Europe's diverse energy storage requirements across utility-scale, commercial & industrial (C&I ), and data center segments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260630889717/en/ EVE Energy showcases its Mr. Giant 3.0 6.9+ MWh energy storage system at The Smarter E Europe 2026 in Munich, Germany Advancing Large-Cell Technology with Global Project Validation As one of the first companies to focus on large-capacity energy storage cells, EVE Energy has iteratively upgraded its cell platform from 560 Ah and 628 Ah to 702 Ah, adhering to a stacking process route throughout. At the exhibition, the Mr. Gia
Bending Spoons S.p.A. announces pricing of initial public offering1.7.2026 01:56:00 CEST | Press release
Bending Spoons S.p.A. (“Bending Spoons”), a leading technology company, today announces the pricing of its initial public offering (“IPO”) at $29.00 per share. A total of 57,971,015 ordinary shares are being offered, of which 34,398,640 shares are being offered by Bending Spoons and 23,572,375 shares are being offered by certain selling shareholders (the “Selling Shareholders”). Bending Spoons will not receive any proceeds from any sale of shares by the Selling Shareholders. The shares are expected to begin trading on the Nasdaq Global Select Market under the ticker symbol “BSP” on July 1, 2026. The offering is expected to close on July 2, 2026, subject to customary closing conditions. In addition, Bending Spoons and the Selling Shareholders granted the underwriters an option to purchase up to an additional 5,244,026 ordinary shares from Bending Spoons and up to an additional 3,451,626 ordinary shares from the Selling Shareholders at the initial public offering price, less underwriting
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom